Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests for the early detection of multiple cancers.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk

Description

Urteste S.A. is a biotechnology company specializing in the development of non-invasive diagnostic technologies for early cancer detection. The company's core focus is on creating a method to detect multiple types of cancer from a single urine sample. This approach aims to identify malignancies at their earliest stages, potentially improving patient survival rates. The development pipeline includes diagnostic tests for various cancers, with projects such as a prototype for detecting brain tumors and planned clinical trials for a pancreatic cancer test.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-02 14:07
Zawiadomienie
Polish PDF 78.3 KB
2026-01-02 14:07
Zawiadomienie o zmianie stanu posiadania akcji Spółki - Content (PL)
Polish HTML 837 bytes
2025-12-30 15:12
Zestawienie zmian
Polish PDF 153.9 KB
2025-12-30 15:12
Statut Spółki
Polish PDF 568.1 KB
2025-12-30 15:12
Rejestracja podwyższenia kapitału zakładowego i zmian w statucie Spółki - Conte…
Polish HTML 3.4 KB
2025-12-23 15:52
Podsumowanie subskrypcji akcji serii G - Content (PL)
Polish HTML 5.9 KB
2025-12-12 11:38
Zawarcie umów objęcia akcji serii G - Content (PL)
Polish HTML 1.8 KB
2025-12-10 10:57
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish HTML 1.6 KB
2025-12-04 17:00
Podjęte uchwały
Polish PDF 294.0 KB
2025-12-04 17:00
Treść uchwał podjętych podczas obrad Nadzwyczajnego Walnego Zgromadzenia w dniu…
Polish HTML 657 bytes
2025-11-28 08:18
Raport kwartalny 3Q2025
Polish PDF 1.2 MB
2025-11-07 16:00
OPINIA ZARZĄDU uzasadniająca powody pozbawienia akcjonariuszy prawa poboru akcji
Polish PDF 178.5 KB
2025-11-07 16:00
Projekty uchwał
Polish PDF 229.9 KB
2025-11-07 16:00
Pełnomocnictwo udzielane przez osoby prawne do uczestnictwa
Polish PDF 160.7 KB
2025-11-07 16:00
Pełnomocnictwo udzielane przez osoby fizyczne do uczestnictwa
Polish PDF 156.4 KB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Urteste S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aptahem AB Logo
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTA
APTAMER GROUP PLC Logo
Develops custom affinity binders for research, diagnostics, and therapeutics.
United Kingdom
APTA
Aptevo Therapeutics Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for cancer.
United States of America
APVO
Biotech firm providing MICROPIG models, bio-resources, and non-clinical CRO services.
South Korea
149300
Aran Research & Development (1982) Ltd. Logo
A product design and development firm providing services from concept to manufacturing.
Israel
ARAN
Artiva Biotherapeutics, Inc. Logo
Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America
ARTV
ARVINAS, INC. Logo
Clinical-stage biopharma developing therapeutics based on targeted protein degradation.
United States of America
ARVN
Asarina Pharma AB Logo
A biotechnology company in liquidation, formerly focused on neurosteroid therapies.
Sweden
ASAP
Atara Biotherapeutics, Inc. Logo
Develops off-the-shelf allogeneic T-cell immunotherapies for cancer and autoimmune diseases.
United States of America
ATRA
An integrated biologics development partner offering services from DNA sequence to cell bank.
South Korea
355690

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.